Collaboration - May 8, 2020
Swedish and Finnish study has found possible vaccine for virus linked to type 1 diabetes
Researchers in Sweden and Finland have produced a vaccine for viruses linked to type 1 diabetes in the hope that it could provide protection against the disease. The study has been published in the scientific journal Science Advances. CVBs could play a part in the development of type 1 diabetes There is a genetic component, […]
Collaboration - April 27, 2020
AstraZeneca collaborates with WWF on water stewardship
AstraZeneca has announced a new collaboration with the World Wide Fund for Nature (WWF) Sweden. The twelve-month partnership will focus on identifying opportunities to improve the company’s approach and strategy towards water stewardship and identify initial opportunities to engage in on-the-ground water projects in the river basins where AstraZeneca operates. Science-Based Targets for Water Together […]
Collaboration - April 17, 2020
Our Spring issue is out!
Read about ongoing progress and challenges in the Nordic life science region, including common efforts to fight the COVID-19 pandemic. The Nordic life science industry, just like all industries, has been affected by the crisis, but our industry also has a very important role in handling this societal crisis. We have scientists collaborating across borders […]
Collaboration - March 25, 2020
AstraZeneca collaborates with Silence Therapeutics
AstraZeneca will collaborate with Silence Therapeutics to discover, develop and commercialize small interfering RNA (siRNA) therapeutics for the treatment of cardiovascular, renal, metabolic and respiratory diseases. This multi-target collaboration will harness Silence’s established siRNA platform to identify and progress liver-based targets, as well as developing new delivery approaches for targeting other tissues such as the […]
Collaboration - March 12, 2020
Zelluna and Karolinska Institutet collaborate
Zelluna Immunotherapy and Karolinska Institutet have announced a collaboration to develop next generation TCR-NK products for the treatment of patients with solid cancers. In addition, Zelluna is entered as a collaborative partner in the new Competence Center for Next-Generation NK Cell-based Cancer Immunotherapy (“NextGenNK”) being established at the KI. Next generation TCR guided NK cells […]
Collaboration - March 9, 2020
Nanoform and Orion collaborate
Nanoform and Orion Corporation have announced a collaboration to apply Nanoform’s CESS technology to new chemical entities. Building on an existing relationship, this collaboration will utilize Nanoform’s CESS technology to improve the bioavailability and solubility of selected early-development compounds, increasing the likelihood of drugs entering clinical development, states the companies. Many new chemical entities struggle […]
